A53T Mutant SNCA Protein Preformed Fibrils (Type 1)

$420.00$1,290.00

The A53T Mutant SNCA Protein Preformed Fibrils (Type 1) is intended for research use only and not for use in diagnostic procedures.

Clear
SKU: SPR-326 Categories: ,

A53T Mutant SNCA Protein Preformed Fibrils (Type 1)

The A53T Mutant SNCA Protein Preformed Fibrils (Type 1) is For Research Use Only

Specificity: ~14.46 kDa
Species: Human
Expression System: E. coli
Buffer: PBS pH 7.4
Storage Temperature: -80ºC
Alternative Names: Active Human Recombinant A53T Mutant Alpha Synuclein Protein Preformed Fibrils (Type 1), A53T mutant alpha synuclein, A53T mutated SNCA, A53T Alpha synuclein PFFs, Ala53thr mutant alpha synuclein, Alpha synuclein pre-formed brils, Alpha synuclein aggregates, Alpha synuclein protein aggregates, Active Alpha synuclein aggregates, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, Alpha synuclein monomers, SYN protein, Parkinson disease familial 1 Protein

Product manufactured in Canada by StressMarq.


Assay Background

Alpha-Synuclein (SNCA) is expressed predominantly in the brain, where it is concentrated in presynaptic nerve terminals. Alpha-synuclein is highly expressed in the mitochondria of the olfactory bulb, hippocampus, striatum and thalamus. Functionally, it has been shown to significantly interact with tubulin, and may serve as a potential microtubule-associated protein. It has also been found to be essential for normal development of the cognitive functions; inactivation may lead to impaired spatial learning and working memory. SNCA fibrillar aggregates represent the major non A-beta component of Alzheimers disease amyloid plaque, and a major component of Lewy body inclusions, and Parkinson’s disease. Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha-synuclein and ubiquitin. The A53T mutation is a missense point mutation where alanine is replaced by threonine at the 53rd amino acid. This mutation has been linked to early-onset Parkinson’s Disease and increased rates of alpha synuclein fibrillization.


Related Products

A53T Mutant SNCA Protein Monomer
Active Human Recombinant Tau (K18), P301L mutant PPF
Active Human Recombinant Tau441 (2N4R), P301S mutant PPF

Additional Information

Comparative Protein Graph


A53T Mutant SNCA Protein Preformed Fibrils (Type 1)

Manual

Product Manual